Sector consensus Lundbeck Nasdaq Copenhagen

Stocks

Market Closed - Nasdaq Copenhagen 11:20:00 2026-09-08 EDT			5-day change	1st Jan Change
43.50 ^DKK	+0.35%		+4.07%	+20.17%

09-08	Barclays raises Lundbeck price target to 50 Danish kroner (48), reiterates equal weight - BN	FW
09-03	H. Lundbeck A/S Highlights Mechanistic Insights and Clinical Data on Bexicaserin At the European Epilepsy Congress	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
MCKESSON CORPORATION				980.73	+8.01%	15
CARDINAL HEALTH, INC.				270.94	+9.61%	16
SIGMA HEALTHCARE LIMITED				3.198	+18.89%	16
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD				20.82	+25.82%	8
HUADONG MEDICINE CO., LTD				41.59	+52.91%	9
H. LUNDBECK A/S				48.88	+12.07%	13
SINOPHARM GROUP CO. LTD.				18.19	+33.87%	15
GALENICA AG	-			87.6	+5.99%	5
SELÇUK ECZA DEPOSU TICARET VE SANAYI				151.87	-58.39%	4
MEDIPAL HOLDINGS CORPORATION				2,950	+0.75%	4
JOINTOWN PHARMACEUTICAL GROUP CO., LTD				5.685	+12.13%	4
CHINA NATIONAL MEDICINES CORPORATION LTD.		-		36.43	+35.53%	2
EBOS GROUP LIMITED		-		23.56	+39.7%	8
SUZUKEN CO., LTD.				6,023.33	+17.6%	3
QINGDAO BAHEAL MEDICAL INC.		-	-	27.31	+16.46%	1
CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.				24.21	+19.02%	4
TOHO HOLDINGS CO., LTD.	-	-		4,050	+2.69%	2
Average				868.49	+14.86%	8
Weighted average by Cap.				628.17	+11.56%	13